Anemia and quality of life including anemia-related symptoms in patients with solid tumors in clinical practice

By Bremberg E.   Brandberg Y.   Hising C.   Friesland S.   Eksborg S.  

Medical Oncology, Vol. 24, Iss. 1, 2007-01 ,pp. : 95-102

Humana Press, Inc

Access to resources Recommend Favorite

Treatment resistance of solid tumors: Role of hypoxia and anemia

By Vaupel Peter   Thews Oliver   Hoeckel Michael  

Medical Oncology, Vol. 18, Iss. 4, 2001-12 ,pp. : 243-259

Humana Press, Inc

Access to resources Recommend Favorite

Constitutional t(8;22) in a patient with myasthenia gravis, leukocytosis, and thrombocytosis

By Keung Y.-K.   Knovich M.A.   Molnar I.   Pettenati M.  

Cancer Genetics and Cytogenetics, Vol. 148, Iss. 1, 2004-01 ,pp. : 87-88

Elsevier

Access to resources Recommend Favorite

Clinical Relevance of Micrometastatic Disease in Patients with Solid Tumors

By Müller V.  

American Journal of Cancer, Vol. 2, Iss. 2, 2003-01 ,pp. : 77-86

Adis International

Access to resources Recommend Favorite

Clinical pharmacokinetics of bevacizumab in patients with solid tumors

By Lu Jian-Feng   Bruno Rene   Eppler Steve   Novotny William   Lum Bert   Gaudreault Jacques  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 5, 2008-10 ,pp. : 779-786

Springer Publishing Company

Access to resources Recommend Favorite